In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Dr. Christopher Klebanoff
Feature
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
In the News
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.
Illustration of immune cell opening as if on hinge and boxing glove coming out.
Q&A
New Approach Could Boost Immunotherapy for Breast Cancer

A protein on certain immune cells is a promising target for making immunotherapy more effective against breast cancer.
Physician-scientist Luc Morris
In the Lab
Clearing the Fog around Tumor Mutational Burden

MSK researchers shed light on how the number of mutations in a tumor affect a patient’s response to immunotherapy drugs.
Physician-scientist Omar Abdel-Wahab
In the Lab
Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective

In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.
Section of a lung cancer tumor in mice
Finding
A Never-Before-Seen Cell State May Explain Cancer’s Ability to Resist Drugs

Identified in mice, this unusual cell state emerges early during tumor evolution and gives tumors enormous malleability.
Crowded hall with ASCO signage
Roundup
Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs

Couldn't make it to the American Society of Clinical Oncology's annual meeting this year? Read this summary of some main takeaways.
Pictured: Timothy Chan
In the Lab
Investigators Sequence the Genome of a Rare Head and Neck Cancer

Investigators have sequenced the genome of adenoid cystic carcinoma, a rare and deadly head and neck cancer. The work sets the stage for the sequencing of additional rare cancers at Memorial Sloan Kettering.
Memorial Sloan Kettering medical oncologist Eileen O'Reilly
Vaccine Targeting KRAS in Pancreatic and Colorectal Cancer Shows Promise

Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.
Detail shot of an MSK scientist in the lab
MSK Research Highlights, January 29, 2024

New MSK research provides insights into how BRCA2 promotes genomic integrity; illuminates how embryonic cells can develop without key amino acids; explores how the microbiome bounces back after antibiotic treatment; and investigates acquired resistance to immunotherapy in non-small cell lung cancer.